These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1007 related articles for article (PubMed ID: 33525993)
21. Depicting the inhibitory potential of polyphenols from Ghosh R; Chakraborty A; Biswas A; Chowdhuri S J Biomol Struct Dyn; 2022 Jun; 40(9):4110-4121. PubMed ID: 33292085 [TBL] [Abstract][Full Text] [Related]
22. Site mapping and small molecule blind docking reveal a possible target site on the SARS-CoV-2 main protease dimer interface. Liang J; Karagiannis C; Pitsillou E; Darmawan KK; Ng K; Hung A; Karagiannis TC Comput Biol Chem; 2020 Dec; 89():107372. PubMed ID: 32911432 [TBL] [Abstract][Full Text] [Related]
23. Novel cyclohexanone compound as a potential ligand against SARS-CoV-2 main-protease. Basu S; Veeraraghavan B; Ramaiah S; Anbarasu A Microb Pathog; 2020 Dec; 149():104546. PubMed ID: 33011363 [TBL] [Abstract][Full Text] [Related]
24. Metadynamics-based enhanced sampling protocol for virtual screening: case study for 3CLpro protein for SARS-CoV-2. Namsani S; Pramanik D; Khan MA; Roy S; Singh JK J Biomol Struct Dyn; 2022 Sep; 40(15):7002-7017. PubMed ID: 33663346 [TBL] [Abstract][Full Text] [Related]
25. Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease. Kandeel M; Al-Nazawi M Life Sci; 2020 Jun; 251():117627. PubMed ID: 32251634 [TBL] [Abstract][Full Text] [Related]
26. Targeting the Dimerization of the Main Protease of Coronaviruses: A Potential Broad-Spectrum Therapeutic Strategy. Goyal B; Goyal D ACS Comb Sci; 2020 Jun; 22(6):297-305. PubMed ID: 32402186 [TBL] [Abstract][Full Text] [Related]
27. Structural and energetic features of the dimerization of the main proteinase of SARS-CoV-2 using molecular dynamic simulations. Zhang Y; Zheng L; Yang Y; Qu Y; Li YQ; Zhao M; Mu Y; Li W Phys Chem Chem Phys; 2022 Feb; 24(7):4324-4333. PubMed ID: 35107451 [TBL] [Abstract][Full Text] [Related]
28. Cysteine focused covalent inhibitors against the main protease of SARS-CoV-2. Paul AS; Islam R; Parves MR; Mamun AA; Shahriar I; Hossain MI; Hossain MN; Ali MA; Halim MA J Biomol Struct Dyn; 2022 Mar; 40(4):1639-1658. PubMed ID: 33047658 [TBL] [Abstract][Full Text] [Related]
30. Discovery of a "Cocktail" of Potential SARS-COV-2 Main Protease Inhibitors through Virtual Screening of Known Chemical Components of Vitex negundo L. ("Lagundi"). Cayona R; Creencia E Med Chem; 2022; 18(3):364-381. PubMed ID: 34148541 [TBL] [Abstract][Full Text] [Related]
31. Potential anti-viral activity of approved repurposed drug against main protease of SARS-CoV-2: an Mahanta S; Chowdhury P; Gogoi N; Goswami N; Borah D; Kumar R; Chetia D; Borah P; Buragohain AK; Gogoi B J Biomol Struct Dyn; 2021 Jul; 39(10):3802-3811. PubMed ID: 32406317 [TBL] [Abstract][Full Text] [Related]
33. Targeting allosteric pockets of SARS-CoV-2 main protease M Bhat ZA; Chitara D; Iqbal J; Sanjeev BS; Madhumalar A J Biomol Struct Dyn; 2022 Sep; 40(14):6603-6618. PubMed ID: 33645457 [TBL] [Abstract][Full Text] [Related]
34. Molecular Binding Mechanism and Pharmacology Comparative Analysis of Noscapine for Repurposing against SARS-CoV-2 Protease. Kumar N; Sood D; van der Spek PJ; Sharma HS; Chandra R J Proteome Res; 2020 Nov; 19(11):4678-4689. PubMed ID: 32786685 [TBL] [Abstract][Full Text] [Related]
35. Elucidation of Binding Features and Dissociation Pathways of Inhibitors and Modulators in SARS-CoV-2 Main Protease by Multiple Molecular Dynamics Simulations. Xu L; Xie L; Zhang D; Xu X Molecules; 2022 Oct; 27(20):. PubMed ID: 36296416 [TBL] [Abstract][Full Text] [Related]
36. Discovery of potent inhibitors for SARS-CoV-2's main protease by ligand-based/structure-based virtual screening, MD simulations, and binding energy calculations. Abu-Saleh AAA; Awad IE; Yadav A; Poirier RA Phys Chem Chem Phys; 2020 Oct; 22(40):23099-23106. PubMed ID: 33025993 [TBL] [Abstract][Full Text] [Related]
37. In silico drug discovery of major metabolites from spices as SARS-CoV-2 main protease inhibitors. Ibrahim MAA; Abdelrahman AHM; Hussien TA; Badr EAA; Mohamed TA; El-Seedi HR; Pare PW; Efferth T; Hegazy MF Comput Biol Med; 2020 Nov; 126():104046. PubMed ID: 33065388 [TBL] [Abstract][Full Text] [Related]
38. Molecular Docking of Azithromycin, Ritonavir, Lopinavir, Oseltamivir, Ivermectin and Heparin Interacting with Coronavirus Disease 2019 Main and Severe Acute Respiratory Syndrome Coronavirus-2 3C-Like Proteases. Arouche TDS; Martins AY; Ramalho TC; JĂșnior RNC; Costa FLP; Filho TSA; Neto AMJC J Nanosci Nanotechnol; 2021 Apr; 21(4):2075-2089. PubMed ID: 33500022 [TBL] [Abstract][Full Text] [Related]